EXFO (Nasdaq: EXFO) reported earnings on Jan. 11. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Nov. 30 (Q1), EXFO missed slightly on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue shrank slightly, and earnings per share dropped significantly.

Gross margins expanded, operating margins dropped, net margins dropped.

Revenue details
EXFO reported revenue of $66 million. The six analysts polled by S&P Capital IQ wanted to see revenue of $67 million. Sales were 1.1% higher than the prior-year quarter's $68 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
Non-GAAP EPS came in at $0.09. The four earnings estimates compiled by S&P Capital IQ predicted $0.08 per share on the same basis. GAAP EPS of $0.05 for Q1 were 78% lower than the prior-year quarter's $0.23 per share.

Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 64.8%, 260 basis points better than the prior-year quarter. Operating margin was 3.7%, 410 basis points worse than the prior-year quarter. Net margin was 4.4%, 1,700 basis points worse than the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods.

Looking ahead
What does the future hold?

Next quarter's average estimate for revenue is $72 million. On the bottom line, the average EPS estimate is $0.10.

Next year's average estimate for revenue is $292 million. The average EPS estimate is $0.41.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 163 members out of 174 rating the stock outperform, and 11 members rating it underperform. Among 33 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 32 give EXFO a green thumbs-up, and one give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on EXFO is hold, with an average price target of $8.07.